Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis

  1. Donna D. Zhang1,6
  1. 1Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, Arizona 85721, USA:
  2. 2Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA;
  3. 3Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan;
  4. 4Institution of Medical Science, Tokyo Medical University, Tokyo 160-8402, Japan;
  5. 5Department of Aerospace and Mechanical Engineering, The University of Arizona, Tucson, Arizona 85721, USA

    Abstract

    Increased endoplasmic reticulum (ER) stress and reactive oxygen species (ROS) are the salient features of end-stage liver diseases. Using liver tissues from liver cirrhosis patients, we observed up-regulation of the XBP1–Hrd1 arm of the ER stress response pathway and down-regulation of the Nrf2-mediated antioxidant response pathway. We further confirmed this negative regulation of Nrf2 by Hrd1 using Hrd1 conditional knockout mice. Down-regulation of Nrf2 was a surprising result, since the high levels of ROS should have inactivated Keap1, the primary ubiquitin ligase regulating Nrf2 levels. Here, we identified Hrd1 as a novel E3 ubiquitin ligase responsible for compromised Nrf2 response during liver cirrhosis. In cirrhotic livers, activation of the XBP1–Hrd1 arm of ER stress transcriptionally up-regulated Hrd1, resulting in enhanced Nrf2 ubiquitylation and degradation and attenuation of the Nrf2 signaling pathway. Our study reveals not only the convergence of ER and oxidative stress response pathways but also the pathological importance of this cross-talk in liver cirrhosis. Finally, we showed the therapeutic importance of targeting Hrd1, rather than Keap1, to prevent Nrf2 loss and suppress liver cirrhosis.

    Keywords

    Footnotes

    • 6 Corresponding authors

      Email dzhang{at}pharmacy.arizona.edu

      E-mail fangd{at}northwestern.edu

    • Supplemental material is available for this article.

    • Article published online ahead of print. Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.238246.114.

    • Received January 13, 2014.
    • Accepted February 24, 2014.

    This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.

    | Table of Contents

    Life Science Alliance